It might not be all of the $25M R&D that is claimable but it would not surprise me if it were a large portion of it.
The figures I based the growth on was conservative but realistic. I'll be more than happy if they achieve better results.
Ann: FY22 Q1 Results - Investor Presentation, page-243
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)